Moderna CEO Eyes European Market to Hit 2028 Breakeven Goals -- Market Talk

Dow Jones

01/14

1113 ET - Moderna is eyeing international markets, especially in Europe, as the company works to hit a breakeven point in 2028, CEO Stéphane Bancel said Monday at the JPMorgan Healthcare Conference. Bancel points out that Pfizer's partnership with the European Union expires at the end of the year, giving Moderna a window to capture a share of the high-volume Covid-19 vaccine market in Europe. If Moderna is able to get European approval for a flu-plus-Covid combo vaccine in 2026, that would also be a positive catalyst for sales growth, he says. The company is also looking to build on partnerships with governments in the United Kingdom, Canada, and Brazil as it looks to drive geographic diversity, Bancel says.(elias.schisgall@wsj.com)

(END) Dow Jones Newswires

January 13, 2026 11:13 ET (16:13 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2603636548"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2603636548\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2603636548?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-14 00:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603636548","market":"hk","top_or_hot":-1,"title":"Moderna CEO Eyes European Market to Hit 2028 Breakeven Goals -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1113 ET - <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> is eyeing international markets, especially in Europe, as the company works to hit a breakeven point in 2028, CEO Stéphane Bancel said Monday at the JPMorgan Healthcare Conference. Bancel points out that Pfizer's partnership with the European Union expires at the end of the year, giving Moderna a window to capture a share of the high-volume Covid-19 vaccine market in Europe. If Moderna is able to get European approval for a flu-plus-Covid combo vaccine in 2026, that would also be a positive catalyst for sales growth, he says. The company is also looking to build on partnerships with governments in the United Kingdom, Canada, and Brazil as it looks to drive geographic diversity, Bancel says.(elias.schisgall@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 13, 2026 11:13 ET (16:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna CEO Eyes European Market to Hit 2028 Breakeven Goals -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna CEO Eyes European Market to Hit 2028 Breakeven Goals -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-01-14 00:13</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1113 ET - <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> is eyeing international markets, especially in Europe, as the company works to hit a breakeven point in 2028, CEO Stéphane Bancel said Monday at the JPMorgan Healthcare Conference. Bancel points out that Pfizer's partnership with the European Union expires at the end of the year, giving Moderna a window to capture a share of the high-volume Covid-19 vaccine market in Europe. If Moderna is able to get European approval for a flu-plus-Covid combo vaccine in 2026, that would also be a positive catalyst for sales growth, he says. The company is also looking to build on partnerships with governments in the United Kingdom, Canada, and Brazil as it looks to drive geographic diversity, Bancel says.(elias.schisgall@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 13, 2026 11:13 ET (16:13 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4568","symbol_name":"美國抗疫概念","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2603636548","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603636548","pubTimestamp":1768320780,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1113 ET - Moderna is eyeing international markets, especially in Europe, as the company works to hit a breakeven point in 2028, CEO Stéphane Bancel said Monday at the JPMorgan Healthcare Conference. Bancel points out that Pfizer's partnership with the European Union expires at the end of the year, giving Moderna a window to capture a share of the high-volume Covid-19 vaccine market in Europe. If Moderna is able to get European approval for a flu-plus-Covid combo vaccine in 2026, that would also be a positive catalyst for sales growth, he says. The company is also looking to build on partnerships with governments in the United Kingdom, Canada, and Brazil as it looks to drive geographic diversity, Bancel says.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4568":"美国抗疫概念","BK4588":"碎股","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","MRNA":"Moderna, Inc.","BK4139":"生物科技","BK4532":"文艺复兴科技持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4501":"段永平概念","BK4551":"寇图资本持仓"},"translate_title":"Moderna首席执行官着眼于欧洲市场实现2028年盈亏平衡目标——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"1113 ET - Moderna is eyeing international markets, especially in Europe, as the company works to hit a breakeven point in 2028, CEO Stéphane Bancel said Monday at the JPMorgan Healthcare Conference. Bancel points out that Pfizer's partnership with the European Union expires at the end of the year, giving Moderna a window to capture a share of the high-volume Covid-19 vaccine market in Europe. If Moderna is able to get European approval for a flu-plus-Covid combo vaccine in 2026, that would also be a positive catalyst for sales growth, he says. The company is also looking to build on partnerships with governments in the United Kingdom, Canada, and Brazil as it looks to drive geographic diversity, Bancel says.(elias.schisgall@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2026 11:13 ET (16:13 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}